Fundamental dimension Equity attribute | ADEXPeer $5.38▲+4.47% Cap $47.88MP/E -5.7x QuantScore21/100 | ACABLeader $5.77— Cap $46.40MP/E -5.7x QuantScore36/100 | ARYDPeer $6.64▼-27.03% Cap $50.04MP/E -30.2x QuantScore31/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
46/100 |
23/100 |
36/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 60/100 | 64/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 29/100 | 25/100 |
Growth Revenue / earnings growth & margins | 17/100 | 33/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -5.7x | -5.7x | -30.2x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -3.4x | 14.3x | 11.0x |
Price / Sales | 2.1x | — | — |
Price / Free Cash Flow | -1.2x | -7.7x | -68.9x |
PEG ratio | -0.06 | 0.06 | 0.32 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 3 / 9 | 2 / 9 |
Altman Z-Score | -0.22 (Distress) | — | 0.99 (Distress) |
Total debt / equity | -0.54 | 0.00 | 0.08 |
Quick ratio | 0.1x | 0.6x | 0.0x |
Interest coverage | -1.4x | -43.4x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -27.5% | -100.0% | — |
Net income growth YoY | -429.5% | +83.4% | -299.9% |
Gross margin (TTM) | 45.3% | 0.0% | 0.0% |
Operating margin (FY) | -88.3% | — | — |
FCF margin (FY) | -183.3% | — | — |
5. Trailing price performancePrice change over period |
1M return | +4.5% | 0.0% | -25.9% |
3M return | -49.7% | -50.3% | -41.9% |
6M return | -49.1% | -48.3% | -40.9% |
Year to date | 0.0% | -45.5% | -39.2% |
1Y return | -47.6% | -45.8% | -38.1% |
3Y return | -44.9% | -41.7% | -32.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | — — | — — | — — |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |